Good evening, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals’ First Quarter 2025 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the ...
SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia (BCDA) ®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results